Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Pabinger

Showing results (331-340 of 367) with videos related to

Pageof 37
Sort By:
Plos One|April 22, 2021
ELISA detection of MPO-DNA complexes in human plasma is error-prone and yields limited information on neutrophil extracellular traps formed in vivoHubert Hayden, Nahla Ibrahim, Johannes Klopf, et al.
Journal of Thrombosis and Haemostasis : JTH|January 11, 2025
Accurate evaluation of factor VIII activity of efanesoctocog alfa in the presence of emicizumabChristophe Nougier, Steven W Pipe, Ingrid Pabinger, et al.
Journal of Clinical Medicine|July 27, 2024
Predelivery Haemostatic Biomarkers in Women with Non-Severe Postpartum HaemorrhageClaire de Moreuil, Brigitte Pan-Petesch, Dino Mehic, et al.
Blood|September 15, 2022
The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia ACihan Ay, Katarina D Kovacevic, Daniel Kraemmer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 25, 2005
Recurrence rate after a first venous thrombosis in patients with familial thrombophiliaCarla Y Vossen, Isobel D Walker, Peter Svensson, et al.
Hamostaseologie|November 13, 2018
Epidemiology and Treatment of Patients with Haemophilia in Austria-Update from the Austrian Haemophilia RegistryJudit Rejtő, Sylvia Reitter-Pfoertner, Sylvia Kepa, et al.
Thrombosis Research|June 13, 2016
Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two dosesSuzanne M Bleker, Andrea Buchmüller, Céline Chauleur, et al.
Wiener Klinische Wochenschrift|October 4, 2014
[Consensus statement: Stroke prevention in nonvalvular atrial fibrillation in special consideration of the new direct oral anticoagulants]Ingrid Pabinger, Wilfried Lang, Franz Xaver Roithinger, et al.
Blood|January 13, 2016
Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trialElena Santagostino, Uri Martinowitz, Toshko Lissitchkov, et al.
JACC. Cardiooncology|January 13, 2025
Early Change in C-Reactive Protein and Venous Thromboembolism in Patients Treated With Immune Checkpoint InhibitorsFlorian Moik, Jakob M Riedl, Dominik Barth, et al.
Pageof 37

Showing results (331-340 of 367) with videos related to

Sort By:
Pageof 37
Plos One|April 22, 2021
ELISA detection of MPO-DNA complexes in human plasma is error-prone and yields limited information on neutrophil extracellular traps formed in vivoHubert Hayden, Nahla Ibrahim, Johannes Klopf, et al.
Journal of Thrombosis and Haemostasis : JTH|January 11, 2025
Accurate evaluation of factor VIII activity of efanesoctocog alfa in the presence of emicizumabChristophe Nougier, Steven W Pipe, Ingrid Pabinger, et al.
Journal of Clinical Medicine|July 27, 2024
Predelivery Haemostatic Biomarkers in Women with Non-Severe Postpartum HaemorrhageClaire de Moreuil, Brigitte Pan-Petesch, Dino Mehic, et al.
Blood|September 15, 2022
The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia ACihan Ay, Katarina D Kovacevic, Daniel Kraemmer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 25, 2005
Recurrence rate after a first venous thrombosis in patients with familial thrombophiliaCarla Y Vossen, Isobel D Walker, Peter Svensson, et al.
Hamostaseologie|November 13, 2018
Epidemiology and Treatment of Patients with Haemophilia in Austria-Update from the Austrian Haemophilia RegistryJudit Rejtő, Sylvia Reitter-Pfoertner, Sylvia Kepa, et al.
Thrombosis Research|June 13, 2016
Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two dosesSuzanne M Bleker, Andrea Buchmüller, Céline Chauleur, et al.
Wiener Klinische Wochenschrift|October 4, 2014
[Consensus statement: Stroke prevention in nonvalvular atrial fibrillation in special consideration of the new direct oral anticoagulants]Ingrid Pabinger, Wilfried Lang, Franz Xaver Roithinger, et al.
Blood|January 13, 2016
Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trialElena Santagostino, Uri Martinowitz, Toshko Lissitchkov, et al.
JACC. Cardiooncology|January 13, 2025
Early Change in C-Reactive Protein and Venous Thromboembolism in Patients Treated With Immune Checkpoint InhibitorsFlorian Moik, Jakob M Riedl, Dominik Barth, et al.
Pageof 37